Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20221116056524N1Phase 3Completed
Phase 3, randomised, double-blind trial of dexmedetomidine in shoulder pain, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Study data collected by questionnaire. Started Mar 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20221116056524N1.